Rapamycin increases the yield and effector function of human γδ T cells stimulated in vitro.
about
The Role of γδ T Cells in Systemic Lupus Erythematosusγδ T cells in cancer immunotherapyRapamycin extends murine lifespan but has limited effects on aging.Targeting γδ T cells for immunotherapy of HIV diseasemTOR Links Environmental Signals to T Cell Fate Decisions.HIV envelope-mediated, CCR5/α4β7-dependent killing of CD4-negative γδ T cells which are lost during progression to AIDSγδ T cells and their potential for immunotherapy.Enhancing adoptive cancer immunotherapy with Vγ2Vδ2 T cells through pulse zoledronate stimulationImmunomodulation at epithelial sites by obesity and metabolic disease.Effect of maintenance immunosuppressive drugs on virus pathobiology: evidence and potential mechanisms.Immunostimulatory activity of lifespan-extending agents.mTOR inhibitors in renal cell carcinoma.Prospects for chimeric antigen receptor (CAR) γδ T cells: A potential game changer for adoptive T cell cancer immunotherapy.Roles of mTOR complexes in the kidney: implications for renal disease and transplantation.Immune-Stimulatory Effects of Rapamycin Are Mediated by Stimulation of Antitumor γδ T Cells.Reduced Incidence of Cytomegalovirus Infection in Kidney Transplant Recipients Receiving Everolimus and Reduced Tacrolimus Doses.Dasatinib promotes the potential of proliferation and antitumor responses of human γδT cells in a long-term induction ex vivo environment.Gamma Delta T Cell Therapy for Cancer: It Is Good to be Local.
P2860
Q26765027-47550168-CEB6-4BE1-9272-D43700F357FAQ28068988-5A80A87D-0290-4162-837F-BF6C2A0CC4D1Q30541884-32A98AF1-1255-4D88-942A-68F98E60A854Q34585223-84C92770-D7EC-4DB0-9179-77DFBAF15800Q34986648-72252C65-83DA-4236-AF2F-0AB4EE5E6D24Q35585948-31E75326-9656-4D59-964E-EC1EC74402F9Q37576001-0527DB95-CA6D-4BBA-ABB7-DBB8CFEAB7BFQ37655345-F3A7A3D5-F2D4-4CC8-A0BB-8CD9D3048095Q37967444-43CBB129-39F6-4A43-B270-D9EA90C971A0Q38061056-D9D9C30D-2C1A-4418-826A-53DBA6857511Q38175673-9FB5FD6E-4DA6-4683-A5B8-36F01040AB0BQ38280462-324F65D6-662F-48E0-97DF-AF7998ABDB45Q38890450-CE00B1F4-1C3F-4808-8AF1-609877718438Q38914374-0FB8258E-9BDF-432B-A60C-04D2DB72363FQ40604193-41C6CBD4-99ED-4487-A1B2-32E89B82DC1BQ41218897-E91E00AF-AAE8-4CBE-9C92-571431541D55Q44222188-4A639B2F-39FD-4FC5-A6FE-7C0568229F0CQ55223108-08481991-1786-4A09-ACCD-28769CF66B01
P2860
Rapamycin increases the yield and effector function of human γδ T cells stimulated in vitro.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Rapamycin increases the yield ...... δ T cells stimulated in vitro.
@ast
Rapamycin increases the yield ...... δ T cells stimulated in vitro.
@en
Rapamycin increases the yield ...... δ T cells stimulated in vitro.
@nl
type
label
Rapamycin increases the yield ...... δ T cells stimulated in vitro.
@ast
Rapamycin increases the yield ...... δ T cells stimulated in vitro.
@en
Rapamycin increases the yield ...... δ T cells stimulated in vitro.
@nl
prefLabel
Rapamycin increases the yield ...... δ T cells stimulated in vitro.
@ast
Rapamycin increases the yield ...... δ T cells stimulated in vitro.
@en
Rapamycin increases the yield ...... δ T cells stimulated in vitro.
@nl
P2860
P1476
Rapamycin increases the yield ...... δ T cells stimulated in vitro.
@en
P2093
C David Pauza
Haishan Li
P2860
P2888
P304
P356
10.1007/S00262-010-0945-7
P577
2010-11-25T00:00:00Z
P5875
P6179
1033552351